Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|January 14, 2016
Transitions to different patterns of interstitial lung disease in scleroderma with and without treatmentHyun J Kim, Donald P Tashkin, David W Gjertson, et al.
The Journal of Physiology|October 7, 2015
Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophyMichael D Nelson, Ryan Rosenberry, Rita Barresi, et al.
Neurology|October 4, 2017
A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophyRonald G Victor, H Lee Sweeney, Richard Finkel, et al.
Neurorehabilitation and Neural Repair|May 18, 2007
Validity of the walking scale for spinal cord injury and other domains of function in a multicenter clinical trialJohn F Ditunno, Hugues Barbeau, Bruce H Dobkin, et al.
Annals of Surgery|October 8, 2003
Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastasesDonald L Morton, Dave S B Hoon, Alistair J Cochran, et al.
European Radiology|September 20, 2011
Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamideHyun J Kim, Matthew S Brown, Robert Elashoff, et al.
Plos Currents|January 31, 2015
Online self-report data for duchenne muscular dystrophy confirms natural history and can be used to assess for therapeutic benefitsRichard T Wang, Cheri A Silverstein Fadlon, J Wes Ulm, et al.
Neuro-Oncology Practice|August 7, 2019
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burdenHuy Tram Nguyen, Nhung Nguyen, Liang Yen Liu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
Lung cancer chemoprevention with celecoxib in former smokersJenny T Mao, Michael D Roth, Michael C Fishbein, et al.
Neuro-Oncology|August 31, 2016
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapyHuyTram N Nguyen, Amy Lie, Tie Li, et al.
Pageof 8